← Back to Screener
iRadimed Corporation (IRMD)
Price$92.93
Favorite Metrics
Price vs S&P 500 (26W)21.99%
Price vs S&P 500 (4W)-15.31%
Market Capitalization$1.19B
P/E Ratio (Annual)52.96x
Indicated Dividend Yield (Annual)0.76%
All Metrics
P/CF (Annual)47.73x
Book Value / Share (Quarterly)$7.40
P/TBV (Annual)13.56x
Indicated Dividend (Annual)$0.68
Revenue Growth (3Y)16.29%
Cash Flow / Share (Quarterly)$1.29
Payout Ratio (TTM)66.90%
Price vs S&P 500 (YTD)-7.81%
Gross Margin (TTM)76.75%
Net Profit Margin (TTM)26.82%
EPS (TTM)$1.75
10-Day Avg Trading Volume0.11M
EPS Excl Extra (TTM)$1.75
Revenue Growth (5Y)21.45%
EPS (Annual)$1.75
Dividend / Share (Annual)$1.18
ROI (Annual)23.76%
Gross Margin (Annual)76.75%
Net Profit Margin (5Y Avg)25.14%
Cash / Share (Quarterly)$4.00
P/E Basic Excl Extra (TTM)52.96x
Revenue Growth QoQ (YoY)17.03%
EPS Growth (5Y)73.86%
P/E Normalized (Annual)52.96x
ROA (Last FY)20.67%
Revenue Growth TTM (YoY)14.43%
EBITD / Share (TTM)$2.30
ROE (5Y Avg)20.07%
Operating Margin (TTM)31.20%
Cash Flow / Share (Annual)$1.29
P/B Ratio12.58x
P/B Ratio (Quarterly)13.08x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)13.60x
Net Interest Coverage (TTM)1096.00x
ROA (TTM)20.83%
EPS Growth QoQ (YoY)24.76%
EV / EBITDA (TTM)38.59x
EPS Incl Extra (Annual)$1.75
Current Ratio (Annual)7.98x
Quick Ratio (Quarterly)6.37x
3-Month Avg Trading Volume0.08M
52-Week Price Return80.35%
EV / Free Cash Flow (Annual)68.95x
P/E Incl Extra (TTM)52.96x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$7.14
P/S Ratio (Annual)14.21x
Asset Turnover (Annual)0.77x
52-Week High$107.90
Operating Margin (5Y Avg)28.91%
EPS Excl Extra (Annual)$1.75
CapEx CAGR (5Y)67.43%
Tangible BV CAGR (5Y)8.59%
26-Week Price Return30.73%
Quick Ratio (Annual)6.37x
13-Week Price Return-7.70%
Total Debt / Equity (Annual)0.00x
Current Ratio (Quarterly)7.98x
Enterprise Value$1,139.473
Revenue / Share Growth (5Y)20.66%
Asset Turnover (TTM)0.78x
Book Value / Share Growth (5Y)8.22%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.77x
Pretax Margin (Annual)33.84%
Cash / Share (Annual)$4.00
3-Month Return Std Dev33.60%
Gross Margin (5Y Avg)76.86%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)116.39%
EBITDA Interim CAGR (5Y)52.22%
ROE (Last FY)23.76%
EPS Basic Excl Extra (Annual)$1.75
P/FCF (TTM)72.05x
Receivables Turnover (TTM)6.92x
EV / Free Cash Flow (TTM)68.95x
Total Debt / Equity (Quarterly)0.00x
EPS Incl Extra (TTM)$1.75
Receivables Turnover (Annual)6.92x
ROI (TTM)23.83%
P/S Ratio (TTM)14.21x
Pretax Margin (5Y Avg)30.81%
Revenue / Share (Annual)$6.52
Tangible BV / Share (Annual)$7.14
Forward P/E46.00x
Free OCF CAGR (5Y)26.12%
Price vs S&P 500 (52W)45.26%
P/E Ratio (TTM)52.96x
EPS Growth TTM (YoY)16.24%
Year-to-Date Return-3.67%
5-Day Price Return0.18%
EPS Normalized (Annual)$1.75
ROA (5Y Avg)17.03%
Net Profit Margin (Annual)26.82%
Month-to-Date Return-2.65%
Cash Flow / Share (TTM)$1.34
EBITD / Share (Annual)$2.14
EPS Growth (3Y)19.89%
Operating Margin (Annual)31.20%
P/CF (TTM)47.73x
ROI (5Y Avg)20.07%
P/E Excl Extra (TTM)52.96x
EPS Basic Excl Extra (TTM)$1.75
P/TBV (Quarterly)13.56x
Payout Ratio (Annual)66.90%
P/B Ratio (Annual)13.08x
Dividend / Share (TTM)$1.18
Inventory Turnover (TTM)1.77x
Pretax Margin (TTM)33.84%
Book Value / Share (Annual)$7.40
Price vs S&P 500 (13W)-10.57%
Net Margin Growth (5Y)44.08%
Dividend Yield (TTM)1.26%
Beta1.03x
P/FCF (Annual)72.05x
Revenue / Share (TTM)$6.50
ROE (TTM)23.83%
52-Week Low$50.00
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.13
4.13
4.13
4.13
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
IRMDiRadimed Corporation | 14.21x | 21.45% | 76.75% | 31.20% | $92.93 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
iRadimed manufactures MRI-compatible medical devices, including non-magnetic IV infusion pump systems and patient vital signs monitors for use during MRI procedures. The company sells to hospitals and acute care facilities in the United States and internationally, with the majority of revenue derived from the U.S. market.